Here we provide comprehensive guidelines for the assessment and treatment of violence and aggression of various etiologies, including psychotic aggression and impulsive aggression due to schizophrenia, mood disorders, ADHD, or trauma, and predatory aggression due to psychopathy and other personality disorders. These guidelines have been developed from a collection of prescribing recommendations, clinical trial results, and years of clinical experience in treating patients who are persistently violent or aggressive in the California Department of State Hospital System. Many of the recommendations provided in these guidelines employ off-label prescribing practices; thus, sound clinical judgment based on individual patient needs and according to institution formularies must be considered when applying these guidelines in clinical practice.
Introduction
Violence and aggression arise from a complex interaction of personal and environmental factors; however, treatment of the violent or aggressive individual often proceeds without an adequate consideration of the sources of the patient's threatening or violent behavior. Furthermore, there are no recent published guidelines about how to assess and treat violence in an inpatient forensic or state hospital system, where most of the patients have diagnoses of psychosis, especially schizophrenia. That is, most published guidelines that discuss the treatment of violence or aggression are focused on one particular diagnosis, such as dementia, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), borderline personality disorder, or intellectual disability. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The published guidelines that do address treatment of violent or aggressive behaviors in a more general sense and across a variety of diagnostic categories were all published nearly a decade or more ago, the most recent being published in 2007. [13] [14] [15] [16] [17] Since the publication of these guidelines, many advances in psychopharmacology have occurred, not the least of which is the introduction of several additional antipsychotic agents. Recent research has also suggested that among psychiatric inpatients, personal factors leading to aggression and violence commonly fall into several broad categories, including psychotic persecutory distortions of reality, increased impulsivity, and antisocial (predatory) personality features, with substance abuse and cognitive impairment frequently playing aggravating comorbid roles with the other domains. 18 Environmental factors may also exert significant influences on the risk of aggressive or violent behavior. While it is recognized that, in many patients, more than one personal or environmental factor may be operative, it is the aim of these guidelines to ask the clinician to generate a data-driven hypothesis regarding the principal or proximate factors that promote the individual's aggression or violence, and then to provide a roadmap for the further evaluation and treatment of the patient. These guidelines make the assumption that a logical, step-wise process of data collection, data analysis, and evidence-based treatment will maximize the probability of resolving or ameliorating the treated person's risk of violent behavior. 19 These guidelines were written for a presumed clinical environment in which, based on level of risk and probable resistance to treatment, the patient may be moved to higher or lower levels of secure care, from a regular hospital unit to an enhanced treatment unit and then to less secure treatment settings as the danger of violence and aggression declines. 20 In order to ease the use of these guidelines in clinical practice, they are presented in a bulleted format with numerous tables and treatment algorithms (many available in the online Supplemental Material).
Overview and Key Points
• 
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• Long-term treatment ○ Note that absence of any adverse effects despite adequate plasma concentrations of antipsychotics may reflect a need for higher-than-standard doses to achieve adequate receptor occupancy (Tables 1  and 2 ) ○ A partial response (<20-30% on the Positive and Negative Syndrome Scale [PANSS] or BPRS) with minimal or no adverse effects argues for a higherdose trial of the present antipsychotic ○ Failure of 2 or more adequate trials of antipsychotics, with at least one being an atypical antipsychotic, argues for a trial of clozapine ○ Tailor treatments to target specific symptoms that may contribute to violence risk (Table 3 and Figure 2 ) ○ There are a variety of pharmacokinetic and drug-drug interaction effects of the anticonvulsants, lithium, and beta blockers that should be considered 
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• Some patients may require higher than cited antipsychotic plasma concentrations to achieve stabilization (Tables 1 and 2 ○ Strongly associated with substance use disorders ○ Past history of psychological trauma increases risk of impulsive aggression and is often comorbid with substance use disorders and personality disorders ○ For mood disorders, the goal of treatment is resolution of the mood symptoms, or improvement to the point that only 1 or 2 symptoms of mild intensity persist ■ Resolution of psychosis is required for remission ○ For patients with mood disorders who do not achieve remission, a reasonable goal is response that entails stabilization of the patient's safety and substantial improvement in the number, intensity, and frequency of mood (and psychotic) symptoms 121 Predatory aggression
•
Confirm that patient's violent and aggressive behaviors result primarily from predatory aggression ○ Purposeful, planned behavior that is associated with attainment of a goal ○ Some patients who engage in predatory acts may have the constellation of personality traits commonly known as psychopathy
• Avoid countertransference reactions (Supplemental Table 3) • Determine potential reasons for predatory aggression (Supplemental Table 4) 65,68,70,122
• Provide opportunities to attain acceptable goals using social learning principles, differential reinforcement, and cognitive restructuring ( Figure 4) 
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• Utilize the Risk-Need-Responsivity principles to determine risk level, treatment needs, and the best way to deliver and optimize treatment (Supplemental Tables 5 and 6) • Regularly evaluate the progress of predatory aggression treatment (Supplemental Table 7 
Conclusion
In conclusion, the task before clinicians who treat violent mentally ill patients is great. We are challenged to help these individuals by whatever means necessary, while at the same time working within the practical restrictions of a hospital setting. The above guidelines will hopefully provide assistance with this task, and can be used as a reference. It is important to remember that many of our patients do not wish to harm others; they are simply struggling to hold themselves together, day in and day out, and it is our duty to help them achieve their highest potential. We must make every attempt to keep all those at our hospitals safe-patients and staff alike. Our concluding thought is to remember that our efforts matter; that by using science, and the best tools available, we can change the course of a life.
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